Home > News > Breakthrough Technologies For 2008
January 17th, 2008
Breakthrough Technologies For 2008
Abstract:
Independent advances in molecular biology, nanotechnology and genetics over the past decade began to converge this year, signaling some notable breakthroughs in medical diagnostics and treatment. Most notable among the successes was the recent IPO of molecular diagnostics company, Nanosphere (nasdaq: NSPH - news - people ). The company's Verigene system leverages nanotechnology to move genetic and protein testing to the point of care, thereby overcoming the time--and cost-intensive limitations of conventional polymerase chain reaction tests.
Nanosphere's current menu of diagnostic tests is limited. I am optimistic long term. Piper Jaffray (nyse: PJC - news - people ) initiated coverage in December with a BUY rating and $17 price target. Meanwhile, analysts for both Credit Suisse and Leerink Swann gave Nanosphere outperform status. The company is a pure-play in the global molecular diagnostics market that, in 2006, measured $2.3 billion according to Boston Biomedical Consultants. The market is projected to grow more than 15% over the next five years.
Source:
forbes.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Energy
KAIST researchers introduce new and improved, next-generation perovskite solar cell November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
Fuel Cells
Current and Future Developments in Nanomaterials and Carbon Nanotubes: Applications of Nanomaterials in Energy Storage and Electronics October 28th, 2022
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||